Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ACAD ACADIA Pharmaceuticals

18.050
-0.010-0.06%
Close 10/05 16:00 ET
High
18.150
Open
17.940
Turnover
22.26M
Low
17.630
Pre Close
18.060
Volume
1.24M
Market Cap
2.92B
P/E(TTM)
Loss
52wk High
28.055
Shares
161.84M
P/E(Static)
Loss
52wk Low
12.240
Float Cap
2.15B
Bid/Ask %
-66.67%
Historical High
58.720
Shs Float
119.04M
Volume Ratio
0.79
Historical Low
0.650
Dividend TTM
--
Div Yield TTM
--
P/B
6.72
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.04%
Amplitude
2.88%
Avg Price
17.989
Lot Size
1
Float Cap
2.15B
Bid/Ask %
-66.67%
Historical High
58.720
Shs Float
119.04M
Volume Ratio
0.79
Historical Low
0.650
Dividend TTM
--
P/B
6.72
Dividend LFY
--
Turnover Ratio
1.04%
Amplitude
2.88%
Avg Price
17.989
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firm's products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
CEO: Mr. Stephen R. Davis
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...